InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Casdin Partners Master Fund, L.P.. Insider active across 5 companies, notably Verve Therapeutics, Inc.. Aggregated, 12 disclosures have been logged. Total volume traded: €39.4m. The latest transaction was filed on 3 August 2021 — C. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
126,185 shares
Common Stock, par value $.001 per share
SEC:0000919574-21-006570·
126,185 shares
Common Stock, par value $.001 per share
SEC:0000919574-21-006570:0·
02,374,849 shares0
Common Stock
SEC:0001209191-21-049765:0·
02,374,849 shares0
Common Stock
SEC:0001209191-21-049765·
€20m1,800,000 shares@ €10.9308100.0% of flow
Common Stock, par value $0.01 per share
SEC:0000919574-21-004808·
Ideal exit: 26 Apr 2022 (T+270)
€20m1,800,000 shares@ €10.930817.66% mcap50.0% of flow
Common Stock, par value $0.01 per share
SEC:0000919574-21-004808:0·
Ideal exit: 26 Apr 2022 (T+270)
04,209,573 shares0
Common Stock
SEC:0001628280-21-014732:0·
04,209,573 shares0
Common Stock
SEC:0001628280-21-014732·
620,571 shares
Common Stock
SEC:0000899243-21-025300:0·
1,007,311 shares
Common Stock
SEC:0000899243-21-025301:0·
620,571 shares
Common Stock
SEC:0000899243-21-025300·
1,007,311 shares
Common Stock
SEC:0000899243-21-025301·
12 of 12 declarations
About Casdin Partners Master Fund, L.P.
Casdin Partners Master Fund, L.P. is a director and insider for several companies, including Verve Therapeutics, Inc. and Absci Corp.
